Bank of Montreal Can decreased its stake in Synopsys, Inc. (NASDAQ:SNPS – Get Rating) by 32.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 127,350 shares of the semiconductor company’s stock after selling 62,118 shares during the period. Bank of Montreal Can owned about 0.08% of Synopsys worth $47,608,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of the stock. Curi Wealth Management LLC bought a new position in shares of Synopsys during the fourth quarter valued at $26,000. Confluence Wealth Services Inc. bought a new position in shares of Synopsys during the fourth quarter valued at $31,000. CVA Family Office LLC bought a new position in shares of Synopsys during the fourth quarter valued at $35,000. Geneos Wealth Management Inc. raised its stake in shares of Synopsys by 105.7% during the fourth quarter. Geneos Wealth Management Inc. now owns 109 shares of the semiconductor company’s stock valued at $40,000 after acquiring an additional 56 shares during the last quarter. Finally, Amplius Wealth Advisors LLC bought a new position in shares of Synopsys during the fourth quarter valued at $40,000. 84.71% of the stock is owned by institutional investors and hedge funds.
Several research firms have recently issued reports on SNPS. Atlantic Securities dropped their price target on shares of Synopsys to $350.00 and set a “na” rating for the company in a research note on Thursday. Needham & Company LLC lifted their target price on shares of Synopsys from $370.00 to $380.00 and gave the stock a “buy” rating in a research note on Thursday. StockNews.com downgraded shares of Synopsys from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, May 3rd. Wells Fargo & Company lowered their target price on shares of Synopsys from $415.00 to $375.00 and set an “overweight” rating for the company in a research note on Thursday. Finally, UBS Group lowered their target price on shares of Synopsys to $360.00 and set a “hold” rating for the company in a research note on Thursday. One analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, Synopsys has an average rating of “Buy” and a consensus price target of $377.45.
Synopsys (NASDAQ:SNPS – Get Rating) last posted its quarterly earnings results on Wednesday, May 18th. The semiconductor company reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.37 by $0.13. Synopsys had a net margin of 21.19% and a return on equity of 18.23%. During the same period in the previous year, the business earned $1.24 earnings per share. On average, research analysts forecast that Synopsys, Inc. will post 5.63 EPS for the current year.
About Synopsys (Get Rating)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that provides virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
- Get a free copy of the StockNews.com research report on Synopsys (SNPS)
- MarketBeat: Week in Review 5/16 – 5/20
- 3 Retailers That Defied First Quarter Headwinds
- Will John Deere’s Earnings Help to Calm the Markets?
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Lowe’s Companies Has Not Bottomed
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.